zepbound tirzepatide patent expiration date These highlights do not include all the information needed to use safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND® (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022 Novo Sues Lilly, Claiming Misleading

Management involves dietary modifications, medications like metoclopramide or erythromycin, and in severe cases, surgical interventions like gastric electrical stimulation or even jejunostomy feeding tubes

Successful outcomes often arise from collaborative efforts, emphasizing that with the right support and tailored interventions, even individuals with significant communication challenges can see remarkable growth and social integration

Among the common side effects these drugs share are gastrointestinal ones, such as nausea, vomiting, constipation, diarrhea, and stomach or abdominal pain

How long can you stay on Tirzepatide